Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 120
Infectious Diseases Drugs 90
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 60
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 44
Drug Discovery 42
Diabetes Drugs 42
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Clinical Trials 35
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 27
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 24
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Oncology 19
Analgesics 18
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Medical Devices 13
Bladder Cancer Drugs 12
Drug Delivery 12
Dermatology 11
Healthcare Services 9
Respiratory Drugs 9
Pharmaceutical Manufacturing 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,135 Results (Page 46 of 57)
- Relevance
  Sort by

Sexually Transmitted Infections (STIs) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Intestine Cancer Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Nasopharyngeal Carcinoma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Checkpoint Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Antibody Drug Conjugates Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Alpha Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1770EUR$2,000USD£1,542GBP

Chronic Obstructive Pulmonary Disorder Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,237USD£3,156GBP

Transplantation Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3137EUR$3,545USD£2,733GBP

€3486EUR$3,939USD£3,037GBP

Spinal Muscular Atrophy - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1770EUR$2,000USD£1,542GBP

Chemotherapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Vulvovaginal Candidiasis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Clotrimazole, Fluconazole, Terconazole), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

 Report
November 2022
100 Pages
Global

From

€5266EUR$5,950USD£4,587GBP

Reversible Anticholinesterases - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1327EUR$1,500USD£1,156GBP

Beta Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1327EUR$1,500USD£1,156GBP

Gene Therapy - Competitive Landscape, 2026

 Report
January 2026
550 Pages
Global

From

€4425EUR$5,000USD£3,855GBP

Antibody-drug Conjugates (ADCs) in Oncology - Competitive Landscape, 2026

 Report
January 2026
450 Pages
Global

From

€4425EUR$5,000USD£3,855GBP

Pruritus Therapeutics Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4204EUR$4,750USD£3,662GBP

Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

 Report
July 2024
200 Pages
Global

From

€4204EUR$4,750USD£3,662GBP

Typhoid Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
93 Pages
Global

From

€3500EUR$4,237USD£3,156GBP

Cholecystokinin Receptor (CCK) Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

1,135 Results (Page 46 of 57)
- 1
- 44
- 45
- 46
- 47
- 48

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.